Skip to Main Content

KMAP BULLETIN: Preferred Drug List Update

Date: 11/10/21

KMAP GENERAL BULLETIN 21217 (PDF)

There is a Preferred Drug List (PDL) update effective November 1, 2021. Reference the Preferred Drug List page on the Kansas Department of Health and Environment (KDHE) website.

The following medications are now non-preferred and a PDL Prior Authorization (PA) is required:

  • Eluxadoline (Viberzi®)
  • Semglee® (insulin glargine-yfgn) – Branded Biosimilar

Effective November 1, 2021, there will not be any removal of PDL PA.

Note: The effective date of the policy is November 1, 2021. The implementation of State policy by the KanCare Managed Care Organizations (MCOs) may vary from the date noted in the Kansas Medical Assistance Program (KMAP) bulletins. The KanCare Open Claims Resolution Log on the KMAP Bulletins page documents the MCO system status for policy implementation and any associated reprocessing completion dates once the policy is implemented.